Research News for July 7, 2021
advertisement
- From Type 1 Diabetes Biology to Therapy: The Human Islet Research Network (HTML)
- Assessment of immune-alternations and their correlations with therapeutic outcomes of transplantation of autologous Mesenchymal and Allogenic fetal stem cells in patients with type 1 diabetes: a study protocol (HTML)
- Prospection of plasma proteins as biomarkers for diabetes mellitus monitoring (HTML)
- Association between IL-18 and IL-6 gene polymorphisms and the risk of T1D in Egyptian children (HTML)
- Means, Motive, and Opportunity: Do Non-Islet-Reactive Infiltrating T Cells Contribute to Autoimmunity in Type 1 Diabetes? (HTML)
- Features of partial remission in children with type 1 diabetes using the insulin dose-adjusted A1c definition and risk factors associated with nonremission (HTML)
- Hemostatic state of children with type 1 diabetes (HTML)
- Pancreas transplant in type 1 diabetes mellitus: the emerging role of islet cell transplant (HTML)
- Islet cell transplantation transitioning to proven therapy for type 1 diabetes (HTML)
- New insights into halting type 1 diabetes
- Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial (HTML)
- Stem Cells as a Source of Pancreatic Cells for Production of 3D Bioprinted Bionic Pancreas in the Treatment of Type 1 Diabetes (HTML)
- Evaluating the Prognostic Value of Islet Autoantibody Monitoring in Islet Transplant Recipients with Long-Standing Type 1 Diabetes Mellitus (HTML)
